Embryonic Stem-cell Therapy

Johnston, S. Laurance
August 2007
PN;Aug2007, Vol. 61 Issue 8, p24
Trade Publication
The article discusses the author's experience as the first American scientist to visit a stem-cell program develop by Dr. Geeta Schroff in India. He has been traveling around the world as part of his research on checking out innovative therapies that has the potential on restoring some function after spinal-cord injury (SCI). He considered Schroff's approach as unique because it transplants embryonic stem cells (ESCs), a procedure only in the planning stages in the U.S. that has the potential. INSET: Stem-Cell Overview.


Related Articles

  • Transplantation of human embryonic stem cell derived oligodendroglial progenitors for the treatment of spinal cord injury  // Molecular Therapy;May2004 Supplement 1, Vol. 9, p89 

    An abstract of the article "Transplantation of Human Embryonic Stem Cell Derived Oligodendroglial Progenitors for the Treatment of Spinal Cord Injury," by Jane Lebkowski, Gabriel Nistor, Giovanna Bernal, Minodora Totoiu, Catherine Priest, Scott Thies, Jerrod Denham and Hans Keirstead is presented.

  • A puromycin selectable cell line for the enrichment of mouse embryonic stem cell-derived V3 interneurons. Xu, Hao; Iyer, Nisha; Huettner, James E.; Sakiyama-Elbert, Shelly E. // Stem Cell Research & Therapy;11/10/2015, Vol. 6, p1 

    Introduction: Spinal V3 interneurons (INs) are a commissural, glutamatergic, propriospinal neuron population that holds great potential for understanding locomotion circuitry and local rewiring after spinal cord injury. Embryonic stem cells hold promise as a cell source. However, the inevitable...

  • Will stem cell therapies be safe and effective for treating spinal cord injuries? Thomas, Katharine E.; Moon, Lawrence D. F. // British Medical Bulletin;Jun2011, Vol. 98 Issue 1, p127 

    Introduction A large number of different cells including embryonic and adult stem cells have been transplanted into animal models of spinal cord injury, and in many cases these procedures have resulted in modest sensorimotor benefits. In October 2010 the world's first clinical trial using human...

  • Behavioral Improvement By Mouse Embryonic Stem Cell Transplantation After Spinal Cord Injury In Rats. Tae-Hoon LEE // Journal of Neurological Sciences;2014, Vol. 31 Issue 2, p232 

    Objectives: We transplanted mouse embryonic stem cells to improve functional loss in a rat model of clip-compression spinal cord injury (SCI). The mouse embryonic stem cells (mESCs) were transplanted to injured cord 7 days after injury. Methods: We have treated undifferentiated mouse embryonic...

  • Stem cell-derived retinal pigment epithelium transplant safe.  // Reactions Weekly;Nov2014, Vol. 1524 Issue 1, p12 

    The article reports on findings of studies which established that human embryonic stem cell (hESC)-derived retinal pigment epithelium transplantation is safe for the treatment of age-related macular degeneration and Stargardt's macular dystrophy.

  • Embryonic Stem Cell-Derived L1 Overexpressing Neural Aggregates Enhance Recovery after Spinal Cord Injury in Mice. Yi-Fang Cui; Jin-Chong Xu; Hargus, Gunnar; Jakovcevski, Igor; Schachner, Melitta; Bernreuther, Christian // PLoS ONE;2011, Vol. 6 Issue 3, p1 

    An obstacle to early stem cell transplantation into the acutely injured spinal cord is poor survival of transplanted cells. Transplantation of embryonic stem cells as substrate adherent embryonic stem cell-derived neural aggregates (SENAs) consisting mainly of neurons and radial glial cells has...

  • Regenerative biology: Brainy stem cells.  // Nature;11/19/2009, Vol. 462 Issue 7271, p255 

    The article reports on the result of a research study about the condition of human embryonic stem cells transplanted into the brain of an irradiated rat, conducted by researcher Charles Limoli and colleagues from the University of California in Irvine, California. The study revealed that the...

  • Introduction: immunopathology and the promise of stem cell research. Preynat-Seauve, Olivier; Villard, Jean // Seminars in Immunopathology;Dec2011, Vol. 33 Issue 6, p517 

    An introduction is presented in which the editor discusses various reports within the issue on topics including obtaining stem cells for regenerative medicine, genetic and immunological barriers to human embryonic stem (ES) cell transplantation, and the use of human ES cells to generate an...

  • Stem-Cell Breakthrough. Underwood, Anne // Newsweek (Atlantic Edition);8/3/2009 (Atlantic Edition), Vol. 154 Issue 5, p48 

    The article examines developments in stem cell research. The world's first clinical trial will begin in 2009 on the use of embryonic stem cells to help repair damaged spinal cords. This reflects the expansion of research on the therapeutic use of stem cells from the replacement of damaged cells...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics